Search
Brain-Computer Interfaces Are on the Verge of Widespread Commercialization
2026-01-19 /
Read about 0 minute
Author：小编
The progress in translating brain-computer interface (BCI) technology from research to clinical application has markedly sped up. Within China, the semi-invasive BCI device, "Brainway No.1," has already been successfully implanted in six patients. Looking ahead, its invasive counterpart, "Brainway No.2," is projected to commence clinical validation in 2026. Meanwhile, invasive BCI products developed by Shanghai Jiedi Medical and Beijing Zhiran Medical have also reached the clinical validation phase. On the global stage, Elon Musk has revealed that mass production of BCI devices is slated for 2026, accompanied by initiatives to automate surgical procedures for their implantation.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
